ELIQUIS SPRINKLE
A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record. FDA lists it under 2 brand names.
- Product
- In this atlas
Overview
Technical summary
Drugs@FDA application NDA220073. Original approval 2025-04-17. No efficacy supplement approvals are on record. 4 products listed.
Trials at a glance
No registry trial in this atlas names this product.
- Regulatory decisions
- 1
Product details
- Type
- Medicine
- Model or formulation
- Dosage forms in the registry record: FOR SUSPENSION; SUSPENSION; TABLET
- Version
- Not stated in the openFDA record
Intended-use sources
No intended-use source is recorded.
The registry's words
Labels as the registry gives them, not rewritten.
- Application
- NDA220073
- Brand name
- ELIQUIS
- Brand name
- ELIQUIS SPRINKLE
- Applicant
- BRISTOL
- Active ingredient
- APIXABAN
- Dosage form
- SUSPENSION
- Dosage form
- TABLET
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
Claims and evidence
Context FDA record read by the openFDA feed
- Recipient
- Recipient not specified
- Population
- Not stated in the openFDA record
- Care setting
- Not stated in the openFDA record
- Geography
- United States (a decision by the US Food and Drug Administration)
- Life stage
- Not stated in the openFDA record
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (regulatory decision)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
FDA records an approval of NDA220073 on 2025-04-17.
Applies to Recipient not specified FDA record read by the openFDA feed
- Certainty method
- Not assessed
- Limitations
- Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked
- Not recorded
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
Supports Drugs@FDA application NDA220073 (openFDA record)
- Locator
- submissions[0].submission_status_date
- How it applies
- The decision date as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
ee45b8b2133853e3cf8f2c96c08e944707321e4ebbdcf6aa93fe218d7b20478b- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA220073 (openFDA record)
- Locator
- application_number
- How it applies
- The registry number of the record.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
ee45b8b2133853e3cf8f2c96c08e944707321e4ebbdcf6aa93fe218d7b20478b- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
-
Supports Drugs@FDA application NDA220073 (openFDA record)
- Locator
- submissions[0].submission_status
- How it applies
- The decision status as the record writes it.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
ee45b8b2133853e3cf8f2c96c08e944707321e4ebbdcf6aa93fe218d7b20478b- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication unless noted (https://open.fda.gov/license/). openFDA says its data is unvalidated and not for medical decisions. The feed commits an extract of the fields it reads, without contact names or addresses, and keeps the raw answer in a private archive named by its sha256.
FDA label
The FDA label of the application holder, as the openFDA label dataset holds it, for this product.
No label from the application holder was found in the openFDA label dataset for application NDA220073. This page does not show another labeler's label in its place.
FDA decisions timeline
The regulatory decisions of the FDA that this atlas holds for this product, oldest first. Each links to its full record.
Authorization
Regulatory decision: ELIQUIS SPRINKLE
- Not stated in the openFDA record
- Not stated in the openFDA record
- United States (a decision by the US Food and Drug Administration)
- Not stated in the openFDA record
- Gestational age Not reported
- Postnatal age Not reported
- Authority
- U.S. Food and Drug Administration
- Decision
- Approval,
- Pathway
- NDA
- Submission
NDA220073- Jurisdictions
- United States
- Product version
- Original application
- Indication
- Not stated in the openFDA record
- Basis
- FDA records an approval of NDA220073 on 2025-04-17.
Limitations. Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
Record details
- Record id
cardio:fdaprod-nda220073- Content hash
1c1a81daa27c234edc8fe220fb2691e5e0907cd71c7ab9f9edc8bd1dd4c21f92